Home/Filings/4/0001955244-25-000015
4//SEC Filing

Berman David M 4

Accession 0001955244-25-000015

CIK 0001671927other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:15 PM ET

Size

14.9 KB

Accession

0001955244-25-000015

Insider Transaction Report

Form 4
Period: 2025-12-04
Berman David M
HEAD OF R&D
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-12-04$17.46/sh+31,341$547,21431,341 total
  • Sale

    Ordinary Shares

    2025-12-04$40.26/sh31,341$1,261,7890 total
  • Exercise/Conversion

    Ordinary Shares

    2025-12-05$17.46/sh+572$9,987572 total
  • Sale

    Ordinary Shares

    2025-12-05$40.14/sh572$22,9600 total
  • Exercise/Conversion

    Employee Share Option (Right to Buy)

    2025-12-0431,34112,404 total
    Exercise: $17.46Exp: 2028-09-12Ordinary Shares (31,341 underlying)
  • Exercise/Conversion

    Employee Share Option (Right to Buy)

    2025-12-0557211,832 total
    Exercise: $17.46Exp: 2028-09-12Ordinary Shares (572 underlying)
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Immediately exercisable.

Issuer

Immunocore Holdings plc

CIK 0001671927

Entity typeother

Related Parties

1
  • filerCIK 0001955244

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:15 PM ET
Size
14.9 KB